Intestinal metabolites predict treatment resistance of patients with depression and anxiety

Juntaro Matsuzaki,Shunya Kurokawa,Chiaki Iwamoto,Katsuma Miyaho,Akihiro Takamiya,Chiharu Ishii,Akiyoshi Hirayama,Kenji Sanada,Shinji Fukuda,Masaru Mimura,Taishiro Kishimoto,Yoshimasa Saito
DOI: https://doi.org/10.1186/s13099-024-00601-3
2024-02-10
Gut Pathogens
Abstract:The impact of the gut microbiota on neuropsychiatric disorders has gained much attention in recent years; however, comprehensive data on the relationship between the gut microbiome and its metabolites and resistance to treatment for depression and anxiety is lacking. Here, we investigated intestinal metabolites in patients with depression and anxiety disorders, and their possible roles in treatment resistance.
gastroenterology & hepatology,microbiology
What problem does this paper attempt to address?